Form 4: USANA Health Sciences Executive Sells Shares

USANA Health Sciences reports a transaction where Chief Commercial Officer Brent Neidig sold 5,002 shares of common stock.

Summary

• Brent Neidig, Chief Commercial Officer of USANA Health Sciences Inc. (USNA), reported a transaction on June 16, 2026.
• The transaction involved the sale of 5,002 shares of common stock.
• The sale was executed at a weighted average price of $19.453 per share, with individual transactions ranging from $19.35 to $19.68.
• Following the transaction, Neidig directly beneficially owns 0 shares of common stock.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the sale of shares by a key executive, although the specific reasons for the sale are not disclosed.

Negatives

• Chief Commercial Officer sold a significant number of shares (5,002).

Future Outlook

No forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings typically report transactions by company insiders, such as officers and directors. These filings are closely watched by investors as they can sometimes signal insider confidence or concerns about the company's stock performance.

Stakeholder Impact

• Shareholders may view the sale of shares by a Chief Commercial Officer with caution, potentially impacting investor sentiment.

Key Dates

Recommendation

This filing reports a routine insider transaction (sale of stock) by a company executive. While such transactions can sometimes be a signal, without further context on the reasons for the sale or other financial performance indicators, a 'hold' recommendation is prudent, suggesting investors monitor for additional information.

Keywords

USANA Health Sciences, USNA, Form 4, insider trading, stock sale, Brent Neidig, Chief Commercial Officer, beneficial ownership